Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
76-90 of 1632 results
Amarantus enters into cGMP manufacturing deal with Catalent Biologics for MANF
Amarantus BioScience Holdings (AMBS), a biotechnology company focused on developing therapeutic and diagnostic products for neurological disorders and orphan indications, announced that it has entered into a manufacturing agreement with Catalent Pharma Solutions (CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, for clinical-grade production of MANF (mesencephalic-astrocyte-derived neurotrophic factor).
Automation > IT & Software > News
Juno Therapeutics acquires Stage Cell Therapeutics
By PBR Staff Writer
US-based Juno Therapeutics has strengthened its multiple capabilities with the acquisition of German biotechnology firm, Stage Cell Therapeutics (Stage).
Automation > IT & Software > News
SteadyMed seeks orphan drug designation from FDA for Trevyent to treat PAH
By PBR Staff Writer
US-based pharmaceutical firm SteadyMed Therapeutics has submitted an application to the US Food and Drug Administration (FDA) seeking orphan drug designation for its lead drug product candidate, Trevyent, to treat pulmonary arterial hypertension (PAH), a rare, progressive, life-threatening disease.
Automation > IT & Software > News
TGA approves Akynzeo to prevent chemotherapy-induced nausea and vomiting (CINV)
Australian biopharmaceutical company Specialised Therapeutics Australia (STA) and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration (TGA) has approved Akynzeo for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
Automation > IT & Software > News
Horizon Discovery, Thermo Fisher enter supply and commercialization agreement
By PBR Staff Writer
UK-based Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific to market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell line collection.
Automation > IT & Software > News
Cyclenium enters into drug discovery collaboration with Haplogen
By PBR Staff Writer
Canada-based Cyclenium Pharma and Austrian biotechnology firm Haplogen have signed a research agreement aimed at the discovery of new pharmaceutical candidates in multiple disease areas.
Automation > IT & Software > News
La Jolla acquires rights to IURTC's next-generation gentamicin derivatives
By PBR Staff Writer
La Jolla Pharmaceutical (La Jolla) has entered into an exclusive option agreement to acquire the Indiana University Research and Technology Center’s (IURTC) intellectual property rights covering next-generation gentamicin derivatives.
Automation > IT & Software > News
Sorrento takes over South American rights to Cynviloq from Samyang
By PBR Staff Writer
Sorrento Therapeutics' fully owned subsidiary, Igdrasol, has acquired exclusive distribution rights to Cynviloq in South America from South Korean firm Samyang Biopharmaceuticals (Samyang).
Automation > IT & Software > News
PeptiDream, Merck enter into peptide discovery collaboration
By PBR Staff Writer
Japanese biopharmaceutical firm PeptiDream has entered into a multi-target discovery and optimization collaboration with US-based Merck for the development of peptides.
Automation > IT & Software > News
Georgia Tech Research provides new cellular sensing platform to develop next-generation bioscience and biotech applications
Researchers from the Georgia Institute of Technology have developed a novel cellular sensing platform that promises to expand the use of semiconductor technology in the development of next-generation bioscience and biotech applications.
Automation > IT & Software > News
Ocata Therapeutics reports positive results in treating macular degeneration using RPE cells
Ocata Therapeutics, a leader in the field of Regenerative Ophthalmology, announced that a study has been published that includes top-line, positive results in Asian patients who were treated with Ocata’s proprietary RPE cells, manufactured using its DeltaCell Technology.
Automation > IT & Software > News
Theraclone to use I-STAR technology to discover therapeutic antibodies against Ebola virus
By PBR Staff Writer
US-based biopharmaceutical firm Theraclone and BIO Ventures for Global Health (BVGH) will collaborate in a project to identify potential therapeutic antibodies against the Ebola virus using I-STAR, the company’s powerful human memory B-cell interrogation platform.
Automation > IT & Software > News
Cypher, Pennsylvania University partner to discover genetic factors in PSP
By PBR Staff Writer
Cypher Genomics and the University of Pennsylvania have entered into a joint research project to discover genetic causes of progressive supranuclear palsy (PSP), a neurodegenerative brain disease.
Automation > IT & Software > News
iBio selects Caliber for production of IBIO-CFB03 for clinical development
iBio has engaged Caliber Biotherapeutics to scale-up and produce materials for clinical development of the first of iBio's proprietary anti-fibrosis products, IBIO-CFB03.
Automation > IT & Software > News
GW Pharmaceuticals gets US patent allowance for use of Cannabidivarin in treating epilepsy
GW Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance for US Application Serial Number 13/075,873, a patent application which covers the use of cannabidivarin (CBDV) for treating epilepsy.
Automation > IT & Software > News
76-90 of 1632 results